Safety, efficacy and biodistribution of an engineered hepatotropic Adeno-Associated Virus mediated gene therapy for Ornithine Transcarbamylase Deficiency in Cynomolgus monkeys

Title
Safety, efficacy and biodistribution of an engineered hepatotropic Adeno-Associated Virus mediated gene therapy for Ornithine Transcarbamylase Deficiency in Cynomolgus monkeys
Authors
Keywords
adeno-associated virus, ornithine transcarbamylase deficiency, engineered capsid, biodistribution, liver, AAV, AAVLK03, non-human primates, cynomolgus macaque, immune response
Journal
Publisher
Elsevier BV
Online
2021-09-14
DOI
10.1016/j.omtm.2021.09.005

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now